---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-338037"
form_type: "8-K"
ticker: "ATTO"
cik: "0002058707"
company_name: "Attovia Therapeutics, Inc."
filed_at: "2026-08-06T20:12:58+00:00"
generated_at: "2026-08-06T20:17:54.848469+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "medium"
source: SEC EDGAR
---

# Attovia Therapeutics closes IPO, adopts amended charter and bylaws

## Summary
- IPO closed on August 6, 2026; amended charter and bylaws became effective.
- Common stock trades on Nasdaq under ticker ATTO.
- Prospectus dated August 4, 2026 describes capital stock provisions.
- Company qualifies as an emerging growth company under SEC rules.

## SEC filing metadata
- accession: 0001193125-26-338037
- form_type: 8-K
- ticker: ATTO
- cik: 0002058707
- company_name: Attovia Therapeutics, Inc.
- filed_at: 2026-08-06T20:12:58+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: medium
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2058707/000119312526338037/0001193125-26-338037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2058707/000119312526338037/d155197d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-338037
- JSON: https://secwatch.observer/filing/0001193125-26-338037.json
- Plain text: https://secwatch.observer/filing/0001193125-26-338037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.